Systemic and specific treatment for a global disease: Allergen immunotherapy revisited

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 61, Issue 7, 2006, Pages 791-795

  Kowalski, M L ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIINFLAMMATORY AGENT; CORTICOSTEROID; DIPHTHERIA TETANUS TOXOID; DNA VACCINE; FLUTICASONE PROPIONATE; IMMUNOGLOBULIN E; INTERLEUKIN 5; LEUKOTRIENE RECEPTOR BLOCKING AGENT; OVALBUMIN; PERTUSSIS VACCINE; PLACEBO; PLASMID DNA; POLLEN ANTIGEN; STEROID; VENOM;

ADOPTIVE TRANSFER; ALLERGIC ASTHMA; ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ALLERGY; BIRCH; BREATH ANALYSIS; BRONCHUS HYPERREACTIVITY; CLINICAL TRIAL; DISEASE SEVERITY; DRUG ADMINISTRATION ROUTE; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; EXHALATION; FOOD ALLERGY; GRASS POLLEN; HUMAN; IMMUNOGENICITY; IMMUNOGLOBULIN PRODUCTION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOTHERAPY; LACTIC ACID BACTERIUM; NONHUMAN; PERENNIAL RHINITIS; POLLEN ALLERGY; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT MUCOSA; TH1 CELL; WHOLE CELL;

ADMINISTRATION, SUBLINGUAL; ALLERGENS; ASTHMA; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; VACCINES;

EID: 33745165209     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2006.01187.x     Document Type: Editorial

References (47)

1. Noon L. Prophylactic inoculation against hay fever. Lancet 1911 2 : 1572 1573.
2. Kay AB. Allergen injection immunotherapy (hyposensitization) on trial. Clin Exp Allergy 1989 19 : 591 596.
3. Bonifazi F Jutel M Bilo BM Birnbaum J Muller U. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy 2005 60 : 1459 1470.
4. Abramson MJ Puy RM Weiner JM. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med 1995 151 : 969 974.
5. Bousquet J Lockey RF Malling HJ, eds. WHO position paper: allergen immunotherapy. Allergy 1998 53 ( Suppl. 44 1 42.
6. Abramson MJ Puy RM Weiner JM. Allergen immunotherapy for asthma. Allergy 1999 54 : 1022 1041. Update in: Cochrane Database Syst Rev. 2003;(4):CD001186.
7. Bousquet J Van Cauwenberge P Khaltaev N. Allergic Rhinitis and its impact on asthma. J Allergy Clin Immunol 2001 108 ( Suppl. 5 S147 S334.
8. GINA Workshop Report. Global strategy for asthma management and prevention. 2005. http://www.ginaasthma.com (Accessed 2 June 2006).
9. Blumberga G Groes L Haugaard L Dahl L. Steroid-sparing effect of subcutaneous SQ-standardized specific immunotherapy in moderate and severe house dust mite allergic asthmatics. Allergy 2006 61 : 841 846.
10. Arvidsson MB Lowhagen O Rak S. Allergen specific immunotherapy attenuates early and late phase reactions in lower airways of birch pollen asthmatic patients: a double blind placebo-controlled study. Allergy 2004 59 : 74 80.
11. Polosa R Li Gotti F Mangano G Paolino G Mastruzzo C Vancheri C et al. Effect of immunotherapy on asthma progression, BHR and sputum eosinophils in allergic rhinitis. Allergy 2004 59 : 1224 1228.
12. Rak S Heinrich C Scheynius A. Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy. Allergy 2005 60 : 643 649.
13. Simpson JL Wood LG Gibson PG. Inflammatory mediators in exhaled breath, induced sputum and saliva. Clin Exp Allergy 2005 35 : 1180 1185.
14. Zitt M. Clinical applications of exhaled nitric oxide for the diagnosis and management of asthma: a consensus report. Clin Ther 2005 27 : 1238 1250.
15. Inci D Altýntaţ DU Kendirli SG Yýlmaz M Karakoç G. The effect of specific immunotherapy on exhaled breath condensate nitrite levels. Allergy 2006 61 : 897 898.
16. Durham SR Walker SM Varga EM Jacobson MR O'Brien F Noble W et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999 341 : 468 475.
17. Des Roches A Paradis L Menardo JL Bouges S Daures JP. Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997 99 : 450 453.
18. Pajno GB Barberio G De Luca F Morabito L Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001 31 : 1392 1397.
19. Moller C Dreborg S Ferdousi HA Halken S Host A Jacobsen L et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol. 2002 109 : 251 256.
20. Niggemann B Jacobsen L Dreborg S Ferdousi HA Halken S Hřst A et al. Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children. Allergy 2006 61 : 853 857.
21. Bufe A Ziegler-Kirbach E Stoeckmann E Heidemann P Gehlhar K Holland-Letz T et al. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Allergy 2004 59 : 498 504.
22. Khinchi MS Poulsen LK Carat F Andre C Hansen AB Malling HJ. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study. Allergy 2004 59 : 45 53.
23. Malling HJ. Methodology and quality of immunotherapy trials. Allergy 2004 59 : 482 484.
24. Tonnel AB Scherpereel A Douay B Mellin B Leprince D Goldstein N et al. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy. Allergy 2004 59 : 491 497.
25. Rolinck-Werninghaus C Staden U Mehl A Hamelmann E Beyer K Niggemann B. Specific oral tolerance induction (SOTI) with food in children: transient or persistent effect on food allergy Allergy 2005 60 : 1320 1322.
26. Bousquet J. Sublingual immunotherapy: from proven prevention to putative rapid relief of allergic symptoms. Allergy 2005 60 : 1 3.
27. Passalacqua G Canonica GW. Sublingual or injection immunotherapy: the final answer Allergy 2004 59 : 37 38.
28. Wilson DR Torres Lima M Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005 60 : 4 12.
29. Rolinck-Werninghaus C Wolf H Liebke C Baars JC Lange J Kopp MV et al. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy 2004 59 : 1285 1293.
30. Ameal A Vega-Chicote JM Fernandez S Miranda A Carmona MJ Rondon MC et al. Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma. Allergy 2005 60 : 1178 1183.
31. Dahl R Stender A Rak S. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis. Allergy 2006 61 : 185 190.
32. Marogna M Spadolini I Massolo A Canonica GW Passalacqua G. Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more. Allergy 2004 59 : 1205.
33. Di Rienzo V Marcucci F Puccinelli P Parmiani S Frati F Sensi L et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy 2003 33 : 206 210.
34. Novembre E Galli E Landi F Caffarelli C Pifferi M De Marco E et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004 114 : 851 857.
35. Cox LS Linnemann DL Nolte H Weldon D Finegold I Nelson HS. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol. 2006 117 : 1021 1035.
36. Bieber T. Allergen-specific sublingual immunotherapy: less mystic, more scientific. Allergy 2006 61 : 149 150.
37. Passalacqua G Pasquali M Ariano R Lombardi C Giardini A Baiardini I et al. Randomized double-blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites. Allergy 2006 61 : 847 852.
38. Agostinis F Tellarini L Canonica GW Falagiani P Passalacqua G. Safety of sublingual immunotherapy with a monomeric allergoid in very young children. Allergy 2005 60 : 133.
39. Taylor A Verhagen J Akdis CA Akdis M. T regulatory cells in allergy and health: a question of allergen specificity and balance. Int Arch Allergy Immunol 2004 135 : 73 82.
40. Jutel M Akdis M Blaser K Akdis CA. Mechanisms of allergen specific immunotherapy - T cell tolerance and more. Allergy 2006 61 : 794 805.
41. Francis JN Durham SR. Adjuvants for allergen immunotherapy: experimental results and clinical perspectives. Curr Opin Allergy Clin Immunol 2004 4 : 543 548.
42. Grüber C Gerhold K von Stuckrad SL Avagyan A Quarcoo D Ahrens B et al. Common vaccine antigens inhibit allergen-induced sensitization and airway hyperresponsiveness in a murine model. Allergy 2006 61 : 818 825.
43. Daniel C Repa A Wild C Pollak A Pot B Breiteneder H et al. Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1. Allergy 2006 61 : 810 817.
44. Broide DH. DNA vaccines: an evolving approach to the treatment of allergic disorders. Allergy Asthma Proc 2005 26 : 195 198.
45. Weiss R Scheiblhofer S Gabler M Ferreira F Leitner WW Thalhamer J. Is genetic vaccination against allergy possible Int Arch Allergy Immunol 2006 139 : 332 345.
46. Leitner WW Hwang LN de Veer MJ Zhou A Silverman RH Williams BR et al. Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat Med 2003 9 : 33 39.
47. Scheiblhofer S Gabler M Leitner WW Bauer R Zögg T Ferreira F et al. Inhibition of type I allergic responses with nanogram doses of replicon-based DNA vaccines. Allergy 2006 61 : 826 833.